Quadruple prenatal screening by most advance
AutoDELFIA immunoassay system is reliable and high-quality results.
Details
Description
Quadruple Maternal Screening test is a
second trimester screening test for pregnant women for pregnant women as this
test to classify a patient as either high-risk or low-risk for chromosomal
abnormalities (Down Syndrome-Trisomy 21, Edward’s Syndrome-Trisomy 18) and
neural tube defects. It identifies the risk of the baby being affected.
This test is done between 14 and 22 weeks
of pregnancy. However, the best time for this test is between 15 and 20 weeks
of pregnancy.
Every pregnant woman is advised to take
this test, for detecting any abnormality in the fetus before birth.
Tests Parameter to check for:
This test measures the levels of four
marker AFP, Unconjugated Estriol, β
-HCG and inhibin A in blood, so known as the Quad Marker test.
AFP is a protein which is produced by the
fetus. If the levels of AFP are high, it indicates neural tube defects in the
fetus or there can be incomplete closure of the fetus abdomen.
Beta-hCG hormone is produced by cells of
the placenta. If the levels of HCG are low, it indicates a miscarriage or
ectopic pregnancy. Whereas, if the levels of HCG are high this indicates
multiple pregnancies.
Estriol is a form of the hormone estrogen
which is present in both fetus and placenta. If the levels of estriol are low,
it indicates the risk of the baby getting delivered with Down syndrome
especially when the levels of AFP are low and HCG are high.
Inhibin A is a hormone which is produced by
the placenta. It is a dimer which means it has two parts. It is also sometimes
referred to as DIA or dimeric inhibin A. In the 14 to 17 weeks of gestation
(pregnancy), the levels of inhibin A in maternal blood slightly decrease and
then rise again. Increased levels of Inhibin A indicate fetus with Down
syndrome. Inhibin A enhances the sensitivity as well as the specificity in
order to correctly identify cases of Down syndrome.
The lab technician will collect blood
sample from the patient. This will be processed in a lab and the report
provided usually fourth day via SMS and Email.
To know more please Call 9801831090, 9801036380(WhatsApp)
Precaution
Test Preparation for combined risk
assessment
Test is valid between 15-22 weeks of
gestation.
Hard copy of your latest pregnancy
ultrasound report (BPD, FL, HC, AC or Level 2),
Both Right & Left Blood pressure
Maternal Screen details (LMP, DOB, Body
Weight, Diabetic status & IVF) ready at the time of your test.